blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1963861

EP1963861 - RNA HELICASE AS MARKER FOR RARE TUMOURS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  14.09.2012
Database last updated on 14.11.2024
Most recent event   Tooltip14.09.2012Application deemed to be withdrawnpublished on 17.10.2012  [2012/42]
Applicant(s)For all designated states
Signalomics GmbH
Leberstrasse 20
1110 Wien / AT
For all designated states
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
200 First Street S.W.
Rochester, MN 55905 / US
[N/P]
Former [2010/44]For all designated states
Signalomics GmbH
Leberstrasse 20
1110 Wien / AT
For all designated states
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
200 First Street S.W.
Rochester, MN 55905 / US
Former [2008/36]For all designated states
Signalomics GmbH
Mariannengasse 14
1090 Wien / AT
For all designated states
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
200 First Street S.W.
Rochester, MN 55905 / US
Inventor(s)01 / ZELLER, Kathrin
Rhönstrasse 3
65520 Bad Camenberg / DE
02 / LAARMANN, Sven
Goldfasanenweg 5
59077 Hamm / DE
03 / MITTMANN, Karin
Mierendorffstrasse 4
48151 Münster / DE
04 / BLOCK, Christoph
Mierendorffstrasse 4
48151 Münster / DE
05 / JANKNECHT, Ralf
1728 Quarry Ridge Place N.W., Apt. 316
Rochester, MN 55901 / US
 [2008/36]
Representative(s)von Renesse, Dorothea, et al
König-Szynka-Tilmann-von Renesse
Patentanwälte Partnerschaft mbB
Postfach 11 09 46
40509 Düsseldorf / DE
[N/P]
Former [2008/46]Von Renesse, Dorothea, et al
König Szynka Tilmann von Renesse Patentanwälte Partnerschaft Lohengrinstrasse 11
40549 Düsseldorf / DE
Former [2008/36]Von Renesse, Dorothea, et al
König-Szynka-Tilmann-von Renesse Patentanwälte Partnerschaft Lohengrinstrasse 11
40549 Düsseldorf / DE
Application number, filing date06829599.714.12.2006
[2008/36]
WO2006EP12042
Priority number, dateUS20050750543P14.12.2005         Original published format: US 750543 P
[2008/36]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2007068478
Date:21.06.2007
Language:DE
[2007/25]
Type: A1 Application with search report 
No.:EP1963861
Date:03.09.2008
Language:DE
The application published by WIPO in one of the EPO official languages on 21.06.2007 takes the place of the publication of the European patent application.
[2008/36]
Search report(s)International search report - published on:EP21.06.2007
ClassificationIPC:G01N33/574, A61K48/00
[2008/36]
CPC:
G01N33/57488 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/36]
TitleGerman:RNA-HELIKASE ALS MARKER FÜR SELTENE TUMORE[2008/36]
English:RNA HELICASE AS MARKER FOR RARE TUMOURS[2008/36]
French:ARN-HELICASE UTILISEE COMME MARQUEUR DE TUMEURS RARES[2008/36]
Entry into regional phase14.07.2008National basic fee paid 
14.07.2008Designation fee(s) paid 
14.07.2008Examination fee paid 
Examination procedure14.07.2008Examination requested  [2008/36]
11.08.2009Despatch of a communication from the examining division (Time limit: M06)
07.06.2010Reply to a communication from the examining division
14.10.2011Despatch of a communication from the examining division (Time limit: M06)
25.04.2012Application deemed to be withdrawn, date of legal effect  [2012/42]
01.06.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2012/42]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  11.08.2009
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
07.06.2010Request for further processing filed
07.06.2010Full payment received (date of receipt of payment)
Fees paidRenewal fee
18.12.2008Renewal fee patent year 03
18.12.2009Renewal fee patent year 04
20.12.2010Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.12.201106   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]EP1241255  (CHUGAI PHARMACEUTICAL CO LTD [JP]) [A] 1-11 * Zusammenfassung, Ansprüche, Seq. ID. Nr. 1 und 2, Fig. 1 *;
 [PA]WO2006091949  (UNIV GEORGIA STATE [US], et al) [PA] 1-11 * Zusammenfassung, Ansprüche *
 [X]  - ABDELHALEEM M, "Do human RNA helicases have a role in cancer?", BBA - REVIEWS ON CANCER, ELSEVIER SCIENCE BV, AMSTERDAM, NL, (20040706), vol. 1704, no. 1, ISSN 0304-419X, pages 37 - 46, XP004517447 [X] 1,2,6,7 * Zusammenfassung, S. 38, Tab. 1, Punkte 2.2, 2.3, 2.10 *

DOI:   http://dx.doi.org/10.1016/j.bbcan.2004.05.001
 [X]  - ABDELHALEEM MOHAMED, "Over-expression of RNA helicases in cancer", ANTICANCER RESEARCH, (200411), vol. 24, no. 6, ISSN 0250-7005, pages 3951 - 3953, XP009081376 [X] 1,2,6,7 * the whole document *
 [X]  - MIYAJI K ET AL, "Overexpression of a DEAD box/RNA helicase protein, rck/p54, in human hepatocytes from patients with hepatitis C virus-related chronic hepatitis and its implication in hepatocellular carcinogenesis.", JOURNAL OF VIRAL HEPATITIS JUL 2003, (200307), vol. 10, no. 4, ISSN 1352-0504, pages 241 - 248, XP002426884 [X] 1,2,6,7 * Zusammenfassung, S. 242, Sp. 1, letzter Absatz, S. 246, Sp. 2, 2. Absatz, S. 246, Sp. 2, 2. Absatz, *

DOI:   http://dx.doi.org/10.1046/j.1365-2893.2003.00447.x
 [X]  - CAUSEVIC M ET AL, "Over expression and Poly-Ubiquitylation of the DEAD-Box RNA Helicase p68 in Colorectal Tumours", ONCOGENE, BASINGSTOKE, HANTS, GB, (2001), vol. 20, ISSN 0950-9232, pages 7734 - 7743, XP002993993 [X] 1,2,6,7,11 * the whole document *

DOI:   http://dx.doi.org/10.1038/sj.onc.1204976
 [A]  - GOH PHUAY-YEE ET AL, "Cellular RNA helicase p68 relocalization and interaction with the hepatitis C virus (HCV) NS5B protein and the potential role of p68 in HCV RNA replication", JOURNAL OF VIROLOGY, (200405), vol. 78, no. 10, ISSN 0022-538X, pages 5288 - 5298, XP002426885 [A] 3,8 * Zusammenfassung, Diskussion *

DOI:   http://dx.doi.org/10.1128/JVI.78.10.5288-5298.2004
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.